Codexis (CDXS) Insider Rahul Singhvi Buys 66,350 Shares
A group of insiders added to their stakes in Codexis, Inc. on June 17, 2026, acquiring 66,350 shares each.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rahul Singhvi bought 66,350 shares of Codexis, Inc. ($CDXS) on June 17, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $CDXS is down 8.5% after 1 week, down 9.7% after 1 month and down 50.0% to date (from the $2.48 close on Jun 17, 2026).
CDXS
Codexis, Inc.
Key Points
- Codexis, Inc. saw a coordinated wave of insider stock purchases on June 17, 2026, involving multiple individuals acquiring identical blocks.
- The stock trades at $2.57, well above its 52-week low of $0.96 and near its 52-week high of $2.98.
- Piper Sandler maintains an overweight rating on the stock with an $8.00 price target as of August 17, 2026.
Get $CDXS trade alerts by text
We text you when insiders, Congress or big funds trade $CDXS. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Codexis, Inc. alert may contain errors. Disclosures
Insider Buying and Selling at Codexis, Inc.
Codexis, Inc. (NasdaqGS: CDXS) recently recorded notable insider transaction activity. On June 17, 2026, a group of individuals tied to the company each picked up blocks of shares. The transactions brought fresh attention to the biotech firm as market participants track insider sentiment.
Details of the Insider Purchases
On June 17, 2026, several insiders added to their holdings in identical transactions. De Vre Raymond acquired 66,350 shares of Codexis, Inc. On the same day, Cynthia Collins also purchased 66,350 shares. Additional buyers stepping up included Dilly Stephen George, who bought 66,350 shares, and Esther Martinborough, who secured 66,350 shares. Further purchases on June 17 involved David Smith and Stewart Parker, who each acquired 66,350 shares of Codexis, Inc. as well.
Stock Performance and Recent Trading Range
Codexis shares change hands at $2.57. The equity has moved between a 52-week low of $0.96 and a 52-week high of $2.98. Its 50-day moving average sits at $1.62, while the 200-day moving average rests at $1.87. The company holds a market capitalization of roughly $151.1 million.
Recent Earnings and Financial Health
For its financial background, Codexis reported revenue of $77.68 million with a revenue growth rate of -2.7%. The firm posted an earnings per share of -0.33, alongside a net margin of -39.55% and a return on equity of -69.36%. Because the company is not currently profitable, it lacks a meaningful positive P/E ratio, though its forward P/E stands at -4.31. The next earnings report is scheduled for November 5, 2026.
Analysts Set New Price Targets
Analyst coverage includes recent updates from major financial firms. On August 17, 2026, Piper Sandler maintained its overweight rating on the stock while adjusting its price target from $9.00 to $8.00. Across seven analyst opinions, the stock carries a consensus buy rating with a mean target price of $6.14, accompanied by a high estimate of $11.00 and a low estimate of $2.00.
About Codexis, Inc.
Headquartered in Redwood City, California, Codexis provides technology solutions aimed at therapeutics manufacturing. The company uses its proprietary CodeEvolver platform to discover and develop novel enzymes. It also builds the ECO Synthesis manufacturing platform to support scaled production for RNAi therapeutics, maintaining relationships with major partners in the life sciences sector.
What to Watch at Codexis, Inc.
Investors will look ahead to the company's upcoming earnings release on November 5, 2026, for further updates on revenue trends and enzymatic platform progress. Market watchers will also track whether additional Form 4 filings appear from corporate insiders as the year progresses.
Related Filing Alerts
Source: Rahul Singhvi's Form 4 filing on $CDXS (Jun 17, 2026). Find the original filing: CDXS Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts